2-aminobutanamide hydrochloride,
2-Aminobutyric acid amide hydrochloride,
89603-48-5,
L-2-Aminobutanamide hydrochloride,
L-2-AMINOBUTYRAMIDE HYDROCHLORIDE,
h-abu(2)-nh2 hcl,
2-Amino-butanamide HCl,
AK-49090,
SCHEMBL373445,
ACMC-209p64,
CTK6C7047,
BCP08675,
MFCD03939986,
USP Levetiracetam Related Compound B,
AKOS015894257,
CM11025,
CS-W000251,
TRA0028450,
(S)-(+)-2-Aminobutyramide hydrochloride,
AK130172,
SY020529,
SY108293,
DB-020516,
(RS)-2-AMINOBUTANAMIDE HYDROCHLORIDE,
AM20120294,
MFCD09265126 (96%),
82A204,
MFCD00136565 (97+%),
I05-0207,
Z1450533767,
h-abu-nh2 hcl,
7682-20-4,
(R)-2-Aminobutanamide hydrochloride,
(S)-2-Aminobutanamide hydrochloride,
(S)-2-Aminobutyramide hydrochloride,
MFCD00136565,
(2S)-2-aminobutanamide Hydrochloride,
(R)-(-)-2-Aminobutanamide hydrochloride,
103765-03-3,